000 | 01571 a2200433 4500 | ||
---|---|---|---|
005 | 20250515031304.0 | ||
264 | 0 | _c20060809 | |
008 | 200608s 0 0 eng d | ||
022 | _a0392-9078 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKusamura, S | |
245 | 0 | 0 |
_aCytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique. _h[electronic resource] |
260 |
_bJournal of experimental & clinical cancer research : CR _cDec 2003 |
||
300 |
_a207-12 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 |
_aChemotherapy, Cancer, Regional Perfusion _xadverse effects |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperthermia, Induced _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPeritoneal Neoplasms _xmortality |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aDeraco, M | |
700 | 1 | _aBaratti, D | |
700 | 1 | _aInglese, M G | |
700 | 1 | _aCostanzo, P | |
700 | 1 | _aFavaro, M | |
700 | 1 | _aManzi, R | |
700 | 1 | _aGavazzi, C | |
773 | 0 |
_tJournal of experimental & clinical cancer research : CR _gvol. 22 _gno. 4 Suppl _gp. 207-12 |
|
999 |
_c16363318 _d16363318 |